Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Testis-specific H1 histone (H1-7) is a member of the linker histone H1 family that is predominantly expressed in male germ cells, particularly in pachytene spermatocytes and early haploid spermatids, where it can constitute up to 55% of total H1 linker histone in chromatin. Like other H1 histones, it binds to the DNA between nucleosomes (linker DNA), facilitating higher-order chromatin compaction and stabilization, and likely plays a distinct role in the establishment of chromatin structure during spermatogenesis. Although H1-7 is highly divergent in its primary sequence compared to somatic H1 isoforms and is the only H1 variant with truly tissue-specific (testis-specific) expression, knockout studies in mice show that its absence does not impair spermatogenesis or fertility, likely due to compensation by other H1 subtypes. There is no evidence that H1-7 directly serves as a therapeutic target or is implicated in specific human diseases. Its biological roles are specialized in meiotic chromatin remodeling and possible facilitation of chromatin transitions required during sperm development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Testis-specific H1 histone (H1-7).